Parathyroid Hormone Market Analysis 2026

Global Parathyroid Hormone Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Parathyroid Hormone Market Report Description

We have various report editions of Parathyroid Hormone Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The April 2025 “Liberation Day Tariffs” (10–46%) have disrupted global pharmaceutical trade, raising costs for APIs, packaging, and machinery from China and India. Generic drug makers, biopharma, vaccines, and CMOs face higher expenses, supply chain delays, and regulatory hurdles, while EU retaliation has further strained U.S. exports. Clinical trials are also delayed due to tariffs on drugs and kits. In this landscape, market research is vital, providing real-time data on pricing, suppliers, and tariff impacts to help companies optimize supply chains, find alternative hubs, and maintain competitiveness.

Parathyroid Hormone Market Insights Video

Competitive Landscape of the Parathyroid Hormone Market

The parathyroid hormone (PTH) market features a competitive landscape dominated by major pharmaceutical companies like Amgen, Novo Nordisk, and Eli Lilly. Key players focus on developing advanced PTH therapies, including treatments for osteoporosis and hypoparathyroidism. Innovation and strategic partnerships are crucial for market positioning. Competitive dynamics are influenced by factors such as product efficacy, regulatory approvals, and market expansion efforts. Companies are also investing in research to address unmet medical needs and enhance treatment outcomes.

In November 2022, Amolyt Pharma announced an oral presentation at the 25th European Congress of Endocrinology (ECE) 2023, highlighting the potential advantages of eneboparatide as a treatment for hypoparathyroidism. This condition often leads to or increases the risk of developing osteopenia and osteoporosis in many individuals. (Source: https://amolytpharma.com/wp-content/uploads/2023/05/2023-05-11-Amolyt-Oral-Presentation-@-ECE-FINAL-English.pdf ) In August 2021, Enzene Biosciences Ltd has been granted Marketing Authorization by the Drug Controller General of India for its biosimilar denosumab, which is used for treating osteoporosis in adults. (Source: https://www.prnewswire.com/in/news-releases/enzene-biosciences-ltd-obtains-a-marketing-authorization-for-its-denosumab-biosimilar-drug-in-india-821614403.html#:~:text=PUNE%2C%20India%2C%20Aug.,treatment%20of%20osteoporosis%20in%20adults. ) In January 2021, Theramex, a pharmaceutical company based in London, has introduced the osteoporosis medication Livogiva in Europe. (Source: https://www.theramex.com/news/theramex-launches-livogiva/ )

Top Companies Market Share in Parathyroid Hormone Industry: (In no particular order of Rank)

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Parathyroid Hormone Market

Which Region Dominates the Parathyroid Hormone Market in 2024?

According to Cognitive Market Research, North America holds the largest market share in the parathyroid hormone (PTH) market due to advanced healthcare infrastructure, high prevalence of osteoporosis, and strong demand for innovative therapies. The region benefits from significant research and development investments, robust regulatory frameworks, and high healthcare expenditure. Additionally, major pharmaceutical companies and a well-established distribution network contribute to market dominance. Increased awareness and early diagnosis further drive the demand for PTH treatments in North America.

Which Region is Expanding at the Fastest CAGR?

The Asia Pacific region is experiencing the fastest CAGR in the parathyroid hormone (PTH) market due to rising awareness of osteoporosis and other related conditions, coupled with improving healthcare infrastructure. Growing urbanization, increasing healthcare expenditure, and a rising elderly population contribute to the demand for advanced PTH therapies. Additionally, expanding pharmaceutical markets and regulatory support for new treatments are driving growth. The region’s economic development and increasing access to medical care further support the market’s rapid expansion.

The current report Scope analyzes Parathyroid Hormone Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (East Africa, West Africa, North Africa, South Africa)

The above graph is for illustrative purposes only.

North America Parathyroid Hormone Market Analysis

According to Cognitive Market Research, the global Parathyroid Hormone market size was estimated at USD 2458.50 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 983.40 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Parathyroid Hormone market with a market size of USD 775.90 million in 2024 and is projected to grow at a CAGR of 2.0% during the forecast period. The U.S. market's advanced healthcare infrastructure, high prevalence of bone disorders, and significant investment in research and development is driving the Parathyroid Hormone market.
• The Canada Parathyroid Hormone market had a market share of USD 118.01 million in 2024 and is projected to grow at a CAGR of 3.0% during the forecast period. Canada’s strong focus on early diagnosis and management of conditions like osteoporosis and hypoparathyroidism is driving the Parathyroid Hormone market.
• The Mexico Parathyroid Hormone market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 89.49 million in 2024.

Europe Parathyroid Hormone Market Analysis

According to Cognitive Market Research, the global Parathyroid Hormone market size was estimated at USD 2458.50 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 737.55 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.5% from 2024 to 2031.

• The United Kingdom Parathyroid Hormone market had a market share of USD 123.91 million in 2024 and is projected to grow at a CAGR of 3.3% during the forecast period. In the UK, Parathyroid Hormone sales witness an upswing due to strong emphasis on advanced healthcare and early diagnosis of bone disorders.
• The France Parathyroid Hormone market is projected to witness growth at a CAGR of 1.7% during the forecast period, with a market size of USD 67.85 million in 2024.
• According to Cognitive Market Research, the German Parathyroid Hormone market size was valued at USD 146.03 million in 2024 and is projected to grow at a CAGR of 2.7% during the forecast period. In Germany, Parathyroid Hormone surged due to presence of major market players.
• The Italy Parathyroid Hormone market is projected to witness growth at a CAGR of 1.9% during the forecast period, with a market size of USD 63.43 million in 2024.
• The Russia Parathyroid Hormone market is projected to witness growth at a CAGR of 1.5% during the forecast period, with a market size of USD 114.32 million in 2024.
• The Spain Parathyroid Hormone market is projected to witness growth at a CAGR of 1.6% during the forecast period with a market size of USD 60.48 million in 2024
• The Luxembourg Parathyroid Hormone market is projected to witness growth at a CAGR of 2.6% during the forecast period, with a market size of USD 22.86 million in 2024.
• The Portugal Parathyroid Hormone market is projected to witness growth at a CAGR of 2.3% during the forecast period, with a market size of USD 15.49 million in 2024.
• The Greece Parathyroid Hormone market is projected to witness growth at a CAGR of 2.8% during the forecast period, with a market size of USD 8.85 million in 2024.
• The Rest of Europe's Parathyroid Hormone market is projected to witness growth at a CAGR of 1.2% during the forecast period, with a market size of USD 114.32 million in 2024.

Asia Pacific Parathyroid Hormone Market Analysis

According to Cognitive Market Research, the global Parathyroid Hormone market size was estimated at USD 2458.50 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 565.46 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Parathyroid Hormone market size was valued at USD 254.45 million in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period. Parathyroid Hormone surged in China due to rising healthcare access, increasing awareness of bone disorders, and a large aging population.
• The Japan Parathyroid Hormone market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 78.03 million in 2024.
• The India Parathyroid Hormone market had a market share of USD 67.85 million in 2024 and is projected to grow at a CAGR of 7.8% during the forecast period. India's rising disposable incomes is driving the Parathyroid Hormone market.
• The South Korean Parathyroid Hormone market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 56.55 million in 2024.
• The Australian Parathyroid Hormone market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 29.40 million in 2024.
• The South East Asia Parathyroid Hormone market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 39.02 million in 2024.
• The Rest of Asia Pacific Parathyroid Hormone market is projected to witness growth at a CAGR of 5.8% during the forecast period, with a market size of USD 40.15 million in 2024.

South America Parathyroid Hormone Market Analysis

According to Cognitive Market Research, the global Parathyroid Hormone market size was estimated at USD 2458.50 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 122.93 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Parathyroid Hormone market size was valued at USD 52.61 million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. Parathyroid Hormones flourished in Brazil due to increasing healthcare access, rising awareness of bone disorders, and expanding medical infrastructure.
• Argentina's Parathyroid Hormone market had a market share of USD 20.65 million in 2024 and is projected to grow at a CAGR of 4.3% during the forecast period. Argentina's improve diagnosis and treatment options is driving the Parathyroid Hormone market.
• Colombia Parathyroid Hormone market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 10.94 million in 2024.
• Peru Parathyroid Hormone market is projected to witness growth at a CAGR of 3.6% during the forecast period, with a market size of USD 10.08 million in 2024.
• Chile Parathyroid Hormone market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 8.85 million in 2024.
• The Rest of Latin America's Parathyroid Hormone market is projected to witness growth at a CAGR of 2.5% during the forecast period, with a market size of USD 19.79 million in 2024.

Middle East Parathyroid Hormone Market Analysis

According to Cognitive Market Research, the global Parathyroid Hormone market size was estimated at USD 2458.50 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 49.17 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031..

• The GCC Countries Parathyroid Hormone market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 21.04 million in 2024. Parathyroid Hormone sales flourish due to the presence of major market players.
• The Egypt Parathyroid Hormone market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 5.16 million in 2024.
• The South Africa Parathyroid Hormone market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 7.77 million in 2024. Parathyroid Hormone sales flourished in South Africa due to increasing awareness and diagnosis of bone disorders, expanding healthcare infrastructure, and rising investments in medical advancements.
• The Turkey Parathyroid Hormone market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 4.23 million in 2024.
• The Nigeria Parathyroid Hormone market is projected to witness growth at a CAGR of 2.8% during the forecast period, with a market size of USD 5.16 million in 2024.
• The Rest of the MEA Parathyroid Hormone market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 5.80 million in 2024.

Author's Conclusion

Author's Detail

Supriya Yadav

Research Analyst

LinkedIn | Profile | Book Appointment

Supriya Yadav is a dedicated market research professional with expertise in the aerospace and defence industry. At Cognitive Market Research, she focuses on delivering strategic insights into aviation advancements, defence technologies, and global security trends shaping the future of the sector.

Her research covers areas such as military modernization, commercial aviation growth, space exploration, and defence procurement strategies. With a strong analytical mindset and attention to technological evolution, Supriya provides data-driven intelligence that supports innovation, strategic planning, and informed decision-making within the aerospace and defence domain.